Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Nicole Golbari,
Stony Brook University School of Medicine
Stonybrook, NY,

Contributing writer Nicole Golbari is a fourth year medical student at Stony Brook University School of Medicine in Stony Brook, New York. She earned her bachelor’s degree in neurobiology from Harvard University in Cambridge, Massachusetts. She is currently completing a one-year clinical research fellowship under the supervision of IPC Board member Dr. Alexa B. Kimball at the Beth Israel Deaconess Medical Center in Boston, Massachusetts.

Last Updated: Apr 15, 2018

Psoriasis News

3/11/2020 1:09:00 PM
For psoriasis patients diagnosed with COVID-19 disease, the IPC recommends physicians discontinue or postpone use of immunosuppressant medications. This is in accordance with established psoriasis treatment guidelines, which state immunosuppressive psoriasis treatments are contraindicated in patients with active infections.
2/6/2020 10:54:00 AM
Just published - IPC's latest issue of the Psoriasis Review newsletter is now available! This issue features the Top Five Papers in psoriasis research, symposia reports, IPC news, and more!
2/6/2020
11/5/2019 9:16:00 AM
AbbVie, a research-based global biopharmaceutical company, today announced the launch of Let Me Be Clear, an empowerment platform for people living with psoriasis. The initiative, which launches on World Psoriasis Day, invites people living with psoriasis to share their story, discuss what freedom from psoriasis would mean to them and access tools to have clear and informed conversations with their physicians.
More News

We use cookies on this website to enhance your experience. By continuing with this website, you consent to our use of cookies. Learn more.
OK